APPLICATION
NDA021723
TYPE
NDA
ORIGINAL APPROVAL
2004-12-30
LATEST ACTION
2004-12-30
ROUTE
ORAL
DOSAGE FORM
CAPSULE
MARKETING STATUS
Prescription
Products
LYRICAPrescription
PREGABALIN 300MG · CAPSULE · ORAL
LYRICAPrescription
PREGABALIN 200MG · CAPSULE · ORAL
LYRICAPrescription
PREGABALIN 100MG · CAPSULE · ORAL
LYRICAPrescription
PREGABALIN 50MG · CAPSULE · ORAL
LYRICAPrescription
PREGABALIN 225MG · CAPSULE · ORAL
LYRICAPrescription
PREGABALIN 150MG · CAPSULE · ORAL
LYRICAPrescription
PREGABALIN 75MG · CAPSULE · ORAL
LYRICAPrescription
PREGABALIN 25MG · CAPSULE · ORAL
Approval history
2004-12-30Type 6 - New Indication (no longer used) · Original · standard — Healthcare Professional Sheet ↗AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.